Amgen Inc.
NASDAQTwo major brokers cut AMGN within 48 hours. The stock is down 14% in a week. Short sellers are adding positions. The signals are aligning — and not in the bulls' favour. BMO Capital struck first on September 8, downgrading Amgen from Outperform to Market Perform while holding its $450 target. HSBC followed on September 10, cutting from Buy to Hold…
AMGN short interest is 2.29% of free float as of September 9, down 4.1% over the past month despite HSBC downgrading the stock to Hold from Buy, cutting its price target to $425 from $445.
A new long-form analysis for AMGN this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumTwo major brokers cut AMGN within 48 hours. The stock is down 14% in a week. Short sellers are adding positions. The signals are aligning — and not in the bulls' favour. BMO Capital struck first on September 8,…
Snapshot as of 20 Sept 2026
AMGN enters the final stretch of August with a notable split: the stock has extended its post-earnings rally while the analyst community is rushing to catch up — and options traders have quietly turned more…
AMGN exits its August 4 earnings print into a wave of upward analyst revisions, with the stock up nearly 3% on the day and a consensus that — for the first time in weeks — has started to catch up to where the shares…
AMGN heads into Tuesday's Q2 report with short sellers still retreating, options traders marginally more defensive, and the stock itself now trading above the average analyst price target — a setup that puts the burden…
AMGN heads into its August 4 earnings report with a 7% week-on-week rally, a sharp drop in short interest, and options traders moving cautiously more defensive — a setup where the longs are winning but the hedgers are…
AMGN continues its quiet grind higher — up another 1.7% on the week to close at $368.10 — yet the analyst community used the move to trim targets rather than lift conviction, leaving the stock in an uncomfortable…
AMGN enters July having quietly put together its best monthly stretch in some time — up 7.5% over the past month and 4.4% on the week to close at $362.12 — yet the rally has done little to shift Wall Street's firmly…
Amgen heads into mid-June with both its short sellers and its options traders moving in the same direction — away from bearish conviction. The short rebuild that had been the dominant positioning story through late…
Amgen enters the first week of June with the defensive options tone that defined late May now visibly fading — while the short rebuild that had been running since mid-April appears to have lost momentum. The clearest…
Amgen heads into the summer with a quietly shifting setup — options traders are more cautious than they've been in months, short interest has been creeping higher for weeks, and the analyst community is clustered just…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AMGN — free to start on ORTEX.
Sign up for free →Open AMGN on ORTEX